Dev, I. K., Dornsife, R. E., Hopper, T. M., Onori, J. A., Miller, C. G., Harrington, L. E., . . . Kumar, R. (2004). Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models. Nature Publishing Group.
Chicago Style aipamenaDev, I K., et al. Antitumour Efficacy of VEGFR2 Tyrosine Kinase Inhibitor Correlates With Expression of VEGF and Its Receptor VEGFR2 in Tumour Models. Nature Publishing Group, 2004.
MLA aipamenaDev, I K., et al. Antitumour Efficacy of VEGFR2 Tyrosine Kinase Inhibitor Correlates With Expression of VEGF and Its Receptor VEGFR2 in Tumour Models. Nature Publishing Group, 2004.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.